Edwards Lifesciences to Present at the Deutsche Bank Healthcare Summit
Get Alerts EW Hot Sheet
Join SI Premium – FREE
IRVINE, Calif.--(BUSINESS WIRE)-- Edwards Lifesciences Corporation (NYSE: EW) will participate in the Deutsche Bank Healthcare Summit on Wednesday, Sept. 16, 2026.
Bernard Zovighian, chief executive officer, is scheduled to present at 10:00 a.m. ET. Doretta Mistras, chief financial officer, will also participate in the conference. A live webcast of the presentation will be available on the Edwards Lifesciences investor relations website at http://ir.edwards.com/, with an archived version accessible later the same day.
About Edwards Lifesciences
Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. Discover more at www.edwards.com and follow us on LinkedIn, Facebook, Instagram and YouTube.
Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260902546110/en/
Media Contact: Eric Endicott, [email protected]
Investor Contact: Gerianne Sarte, [email protected]
Source: Edwards Lifesciences Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EdgeConneX Joins Singapore’s Sustainable Tropical Data Centre Testbed 2.0 as Top-Tier Anchor Partner
- Beau Parmenter Brings Business Leadership and Public Service Focus to a Healthier Michigan
- CNCF Welcomes New Silver Members as Enterprises Scale AI From Training to Inference
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
Deutsche BankSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share